Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age. (Q44362007)
Jump to navigation
Jump to search
scientific article published on 13 March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age. |
scientific article published on 13 March 2003 |
Statements
1 reference
Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age. (English)
1 reference
Linda Mileshkin
1 reference
James J Biagi
1 reference
Paul Mitchell
1 reference
Craig Underhill
1 reference
Andrew Grigg
1 reference
Richard Bell
1 reference
Joe McKendrick
1 reference
Peter Briggs
1 reference
John F Seymour
1 reference
Kate Lillie
1 reference
Jennifer G Smith
1 reference
Jerome B Zeldis
1 reference
H Miles Prince
1 reference
13 March 2003
1 reference
1 reference
102
1 reference
1
1 reference
69-77
1 reference
Identifiers
1 reference
1 reference